

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 8.03210765 |
| 2 | central nervous system myelination (GO:0022010) | 6.94645103 |
| 3 | axon ensheathment in central nervous system (GO:0032291) | 6.94645103 |
| 4 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.68818387 |
| 5 | actin-myosin filament sliding (GO:0033275) | 5.74162065 |
| 6 | muscle filament sliding (GO:0030049) | 5.74162065 |
| 7 | cholesterol biosynthetic process (GO:0006695) | 5.72952210 |
| 8 | sterol biosynthetic process (GO:0016126) | 5.12007125 |
| 9 | actin-mediated cell contraction (GO:0070252) | 4.82470499 |
| 10 | regulation of skeletal muscle contraction (GO:0014819) | 4.76054223 |
| 11 | axon ensheathment (GO:0008366) | 4.54803481 |
| 12 | ensheathment of neurons (GO:0007272) | 4.54803481 |
| 13 | myelination (GO:0042552) | 4.51711419 |
| 14 | isoprenoid biosynthetic process (GO:0008299) | 4.47565916 |
| 15 | amyloid precursor protein metabolic process (GO:0042982) | 4.37867518 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.35921623 |
| 17 | platelet dense granule organization (GO:0060155) | 4.33454681 |
| 18 | proteasome assembly (GO:0043248) | 4.07679298 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 4.05006122 |
| 20 | skeletal muscle contraction (GO:0003009) | 4.03675287 |
| 21 | ubiquinone biosynthetic process (GO:0006744) | 4.00367809 |
| 22 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.97857107 |
| 23 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.92520145 |
| 24 | response to redox state (GO:0051775) | 3.88785410 |
| 25 | behavioral response to nicotine (GO:0035095) | 3.85624873 |
| 26 | regulation of collateral sprouting (GO:0048670) | 3.79535297 |
| 27 | protein complex biogenesis (GO:0070271) | 3.70601887 |
| 28 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.69421073 |
| 29 | amyloid precursor protein catabolic process (GO:0042987) | 3.68910536 |
| 30 | protein neddylation (GO:0045116) | 3.67274983 |
| 31 | ubiquinone metabolic process (GO:0006743) | 3.66055824 |
| 32 | GPI anchor biosynthetic process (GO:0006506) | 3.66006128 |
| 33 | adhesion of symbiont to host cell (GO:0044650) | 3.62016826 |
| 34 | virion attachment to host cell (GO:0019062) | 3.62016826 |
| 35 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.61250432 |
| 36 | NADH dehydrogenase complex assembly (GO:0010257) | 3.61250432 |
| 37 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.61250432 |
| 38 | sarcomere organization (GO:0045214) | 3.52701015 |
| 39 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.50093345 |
| 40 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.48683670 |
| 41 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.46464468 |
| 42 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.43792229 |
| 43 | creatine metabolic process (GO:0006600) | 3.42761525 |
| 44 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.40244067 |
| 45 | sphingoid metabolic process (GO:0046519) | 3.38562754 |
| 46 | response to lipoprotein particle (GO:0055094) | 3.37078041 |
| 47 | sphingosine metabolic process (GO:0006670) | 3.33970584 |
| 48 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.32710421 |
| 49 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.30978186 |
| 50 | otic vesicle formation (GO:0030916) | 3.30486120 |
| 51 | negative regulation of protein localization to cell surface (GO:2000009) | 3.29934751 |
| 52 | kynurenine metabolic process (GO:0070189) | 3.27695235 |
| 53 | heart process (GO:0003015) | 3.24930358 |
| 54 | heart contraction (GO:0060047) | 3.24930358 |
| 55 | keratinocyte development (GO:0003334) | 3.24788309 |
| 56 | striated muscle contraction (GO:0006941) | 3.24414379 |
| 57 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.24105245 |
| 58 | ATP synthesis coupled proton transport (GO:0015986) | 3.23083337 |
| 59 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.23083337 |
| 60 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.22505941 |
| 61 | positive regulation of actin filament depolymerization (GO:0030836) | 3.21136990 |
| 62 | chaperone-mediated protein transport (GO:0072321) | 3.19444949 |
| 63 | adenosine metabolic process (GO:0046085) | 3.18772009 |
| 64 | estrogen biosynthetic process (GO:0006703) | 3.18497686 |
| 65 | nucleotide transmembrane transport (GO:1901679) | 3.17409153 |
| 66 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.17232405 |
| 67 | response to inactivity (GO:0014854) | 3.16543694 |
| 68 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.15940111 |
| 69 | cornea development in camera-type eye (GO:0061303) | 3.13887793 |
| 70 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.11480910 |
| 71 | termination of RNA polymerase III transcription (GO:0006386) | 3.11480910 |
| 72 | GPI anchor metabolic process (GO:0006505) | 3.11262359 |
| 73 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.09097746 |
| 74 | signal peptide processing (GO:0006465) | 3.08395482 |
| 75 | sequestering of actin monomers (GO:0042989) | 3.07642708 |
| 76 | photoreceptor cell differentiation (GO:0046530) | 3.06471248 |
| 77 | eye photoreceptor cell differentiation (GO:0001754) | 3.06471248 |
| 78 | regulation of sequestering of triglyceride (GO:0010889) | 3.05606563 |
| 79 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.05409029 |
| 80 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.05409029 |
| 81 | L-methionine salvage (GO:0071267) | 3.04908982 |
| 82 | L-methionine biosynthetic process (GO:0071265) | 3.04908982 |
| 83 | amino acid salvage (GO:0043102) | 3.04908982 |
| 84 | respiratory chain complex IV assembly (GO:0008535) | 3.03377691 |
| 85 | myofibril assembly (GO:0030239) | 3.02743667 |
| 86 | DNA deamination (GO:0045006) | 3.01259710 |
| 87 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.99573523 |
| 88 | diol metabolic process (GO:0034311) | 2.97918615 |
| 89 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.97596139 |
| 90 | quinone biosynthetic process (GO:1901663) | 2.97445624 |
| 91 | cullin deneddylation (GO:0010388) | 2.97359292 |
| 92 | phosphatidylserine metabolic process (GO:0006658) | 2.96225600 |
| 93 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.94999085 |
| 94 | positive regulation of mitochondrial fission (GO:0090141) | 2.92829648 |
| 95 | actin filament-based movement (GO:0030048) | 2.92662784 |
| 96 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.91794632 |
| 97 | aspartate family amino acid catabolic process (GO:0009068) | 2.91417236 |
| 98 | somite development (GO:0061053) | 2.89745841 |
| 99 | positive regulation of pseudopodium assembly (GO:0031274) | 2.89531841 |
| 100 | cyclooxygenase pathway (GO:0019371) | 2.88846286 |
| 101 | myotube cell development (GO:0014904) | 2.88212492 |
| 102 | response to muscle activity (GO:0014850) | 2.87921339 |
| 103 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.86905698 |
| 104 | peptidyl-histidine modification (GO:0018202) | 2.86461950 |
| 105 | substantia nigra development (GO:0021762) | 2.86258940 |
| 106 | amino sugar catabolic process (GO:0046348) | 2.86240380 |
| 107 | regulation of cilium movement (GO:0003352) | 2.85530953 |
| 108 | oxidative phosphorylation (GO:0006119) | 2.83654591 |
| 109 | acyl-CoA biosynthetic process (GO:0071616) | 2.83577262 |
| 110 | thioester biosynthetic process (GO:0035384) | 2.83577262 |
| 111 | peripheral nervous system axon ensheathment (GO:0032292) | 2.83224330 |
| 112 | myelination in peripheral nervous system (GO:0022011) | 2.83224330 |
| 113 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.82405233 |
| 114 | alcohol biosynthetic process (GO:0046165) | 2.81723634 |
| 115 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.81672589 |
| 116 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.81672589 |
| 117 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 2.79933532 |
| 118 | glycosylceramide metabolic process (GO:0006677) | 2.79560194 |
| 119 | regulation of sarcomere organization (GO:0060297) | 2.78497093 |
| 120 | tissue regeneration (GO:0042246) | 2.77928097 |
| 121 | protein deneddylation (GO:0000338) | 2.77675018 |
| 122 | muscle fiber development (GO:0048747) | 2.76489183 |
| 123 | regulation of pseudopodium assembly (GO:0031272) | 2.76245246 |
| 124 | mannosylation (GO:0097502) | 2.76164378 |
| 125 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.74681621 |
| 126 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.73788589 |
| 127 | alditol phosphate metabolic process (GO:0052646) | 2.73732584 |
| 128 | skeletal muscle fiber development (GO:0048741) | 2.73152447 |
| 129 | cytochrome complex assembly (GO:0017004) | 2.72340491 |
| 130 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.71813236 |
| 131 | indole-containing compound catabolic process (GO:0042436) | 2.71215783 |
| 132 | indolalkylamine catabolic process (GO:0046218) | 2.71215783 |
| 133 | tryptophan catabolic process (GO:0006569) | 2.71215783 |
| 134 | myelin maintenance (GO:0043217) | 2.71124090 |
| 135 | establishment of skin barrier (GO:0061436) | 2.70501641 |
| 136 | intestinal epithelial cell development (GO:0060576) | 2.69356694 |
| 137 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.68992486 |
| 138 | adhesion of symbiont to host (GO:0044406) | 2.67949856 |
| 139 | regulation of glucokinase activity (GO:0033131) | 2.66732565 |
| 140 | regulation of hexokinase activity (GO:1903299) | 2.66732565 |
| 141 | L-amino acid import (GO:0043092) | 2.65499252 |
| 142 | magnesium ion transport (GO:0015693) | 2.65426756 |
| 143 | branched-chain amino acid catabolic process (GO:0009083) | 2.65335609 |
| 144 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.64717974 |
| 145 | regulation of water loss via skin (GO:0033561) | 2.64607493 |
| 146 | respiratory electron transport chain (GO:0022904) | 2.64030961 |
| 147 | autophagic vacuole fusion (GO:0000046) | 2.63890953 |
| 148 | terpenoid biosynthetic process (GO:0016114) | 2.63881153 |
| 149 | 7-methylguanosine mRNA capping (GO:0006370) | 2.63715260 |
| 150 | import into cell (GO:0098657) | 2.61511700 |
| 151 | glycerophospholipid catabolic process (GO:0046475) | 2.61437130 |
| 152 | muscle contraction (GO:0006936) | 2.61399280 |
| 153 | regulation of cell communication by electrical coupling (GO:0010649) | 2.60123858 |
| 154 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.60047456 |
| 155 | negative regulation of ligase activity (GO:0051352) | 2.60047456 |
| 156 | proton transport (GO:0015992) | 2.58303420 |
| 157 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.58177700 |
| 158 | electron transport chain (GO:0022900) | 2.57443896 |
| 159 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.57221755 |
| 160 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.57220913 |
| 161 | RNA capping (GO:0036260) | 2.57164729 |
| 162 | 7-methylguanosine RNA capping (GO:0009452) | 2.57164729 |
| 163 | cytidine metabolic process (GO:0046087) | 2.56984376 |
| 164 | cytidine catabolic process (GO:0006216) | 2.56984376 |
| 165 | cytidine deamination (GO:0009972) | 2.56984376 |
| 166 | indolalkylamine metabolic process (GO:0006586) | 2.55815428 |
| 167 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.55277042 |
| 168 | hydrogen ion transmembrane transport (GO:1902600) | 2.54595813 |
| 169 | hydrogen transport (GO:0006818) | 2.54505041 |
| 170 | regulation of actin filament-based movement (GO:1903115) | 2.53773619 |
| 171 | negative regulation of telomere maintenance (GO:0032205) | 2.53142472 |
| 172 | fatty acid transmembrane transport (GO:1902001) | 2.52783206 |
| 173 | cardiac myofibril assembly (GO:0055003) | 2.51955408 |
| 174 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.51455683 |
| 175 | lysine catabolic process (GO:0006554) | 2.51264486 |
| 176 | lysine metabolic process (GO:0006553) | 2.51264486 |
| 177 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.50792002 |
| 178 | adult heart development (GO:0007512) | 2.49278175 |
| 179 | tryptophan metabolic process (GO:0006568) | 2.49201250 |
| 180 | nonmotile primary cilium assembly (GO:0035058) | 2.48564601 |
| 181 | protein-cofactor linkage (GO:0018065) | 2.47353745 |
| 182 | negative regulation of response to food (GO:0032096) | 2.46813986 |
| 183 | negative regulation of appetite (GO:0032099) | 2.46813986 |
| 184 | regulation of membrane repolarization (GO:0060306) | 2.46412694 |
| 185 | limb bud formation (GO:0060174) | 2.45933088 |
| 186 | synaptic transmission, cholinergic (GO:0007271) | 2.45891414 |
| 187 | lipid particle organization (GO:0034389) | 2.45679650 |
| 188 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.38437395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.50460728 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.45758464 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.89160240 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.73493886 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.65394492 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.50255618 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.93142226 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.84482238 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.76359682 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.70136474 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.44874496 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.34248539 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.32969085 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.31059980 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.30620590 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.21459109 |
| 17 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.17886644 |
| 18 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.16901393 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.15759540 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10895268 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.10665847 |
| 22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.06353980 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.01481507 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.00566785 |
| 25 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.94387411 |
| 26 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.94387411 |
| 27 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.94387411 |
| 28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.93687844 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.90418094 |
| 30 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.89346068 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88062950 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.87595793 |
| 33 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.87258162 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.86269927 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86073165 |
| 36 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.80136320 |
| 37 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.77200453 |
| 38 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.70511442 |
| 39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68339314 |
| 40 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.56509241 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53551827 |
| 42 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.47926672 |
| 43 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.46927248 |
| 44 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.45328741 |
| 45 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45022587 |
| 46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45022587 |
| 47 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.42251852 |
| 48 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.42235405 |
| 49 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42187821 |
| 50 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.41107422 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.38757460 |
| 52 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37810864 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.37498883 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36647897 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.35828935 |
| 56 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.35452297 |
| 57 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.35253480 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35027333 |
| 59 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35004905 |
| 60 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35004905 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34868114 |
| 62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.33854408 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31183731 |
| 64 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.30241140 |
| 65 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.29490773 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27745973 |
| 67 | AR_20517297_ChIP-Seq_VCAP_Human | 1.27578355 |
| 68 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.26214380 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23944526 |
| 70 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23805467 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23369382 |
| 72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.23034109 |
| 73 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.22471825 |
| 74 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.21898189 |
| 75 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.21561742 |
| 76 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21383488 |
| 77 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.21089436 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20018615 |
| 79 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.19047236 |
| 80 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.19047236 |
| 81 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.18260818 |
| 82 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.18040608 |
| 83 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.17121545 |
| 84 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.16162986 |
| 85 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15604421 |
| 86 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.14772481 |
| 87 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14347001 |
| 88 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12893093 |
| 89 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12659718 |
| 90 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12441311 |
| 91 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.12157493 |
| 92 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11314807 |
| 93 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.11190075 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08687629 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08641214 |
| 96 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.07931613 |
| 97 | NCOR_22424771_ChIP-Seq_293T_Human | 1.06887400 |
| 98 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05164808 |
| 99 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02028909 |
| 100 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00967212 |
| 101 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00962672 |
| 102 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00690263 |
| 103 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00208121 |
| 104 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99999196 |
| 105 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99866216 |
| 106 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99778045 |
| 107 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99321174 |
| 108 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.98828092 |
| 109 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98459933 |
| 110 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.97730407 |
| 111 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97595527 |
| 112 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97088089 |
| 113 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.96876546 |
| 114 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.96844958 |
| 115 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.96424606 |
| 116 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96238695 |
| 117 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96081507 |
| 118 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.94945562 |
| 119 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94382731 |
| 120 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93905920 |
| 121 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.93893716 |
| 122 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.93672537 |
| 123 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93415575 |
| 124 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92454077 |
| 125 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92120625 |
| 126 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90382211 |
| 127 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.89477245 |
| 128 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89252649 |
| 129 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.88276455 |
| 130 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.88230093 |
| 131 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86500813 |
| 132 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85965285 |
| 133 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.85098381 |
| 134 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84690568 |
| 135 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.84572340 |
| 136 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.83615866 |
| 137 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.81313478 |
| 138 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80480988 |
| 139 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80099272 |
| 140 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.78353690 |
| 141 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.77410368 |
| 142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.76605390 |
| 143 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74741386 |
| 144 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.74733001 |
| 145 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.74579705 |
| 146 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.74518894 |
| 147 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.74518894 |
| 148 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.74395649 |
| 149 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73690295 |
| 150 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.71562714 |
| 151 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71480557 |
| 152 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.70762316 |
| 153 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.70762316 |
| 154 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.70505970 |
| 155 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70012021 |
| 156 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.67999007 |
| 157 | EWS_26573619_Chip-Seq_HEK293_Human | 0.67827790 |
| 158 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.67511556 |
| 159 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.67511174 |
| 160 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.67226569 |
| 161 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66821690 |
| 162 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.66449303 |
| 163 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.66378764 |
| 164 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.66096486 |
| 165 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.64904047 |
| 166 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.64490003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.16329723 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 4.31180236 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 4.08719313 |
| 4 | MP0000920_abnormal_myelination | 3.74485368 |
| 5 | MP0000751_myopathy | 3.62020227 |
| 6 | MP0000749_muscle_degeneration | 3.54460710 |
| 7 | MP0003950_abnormal_plasma_membrane | 3.19898891 |
| 8 | MP0008260_abnormal_autophagy | 3.01425333 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.99633335 |
| 10 | MP0003136_yellow_coat_color | 2.92561390 |
| 11 | MP0005275_abnormal_skin_tensile | 2.82165201 |
| 12 | MP0005171_absent_coat_pigmentation | 2.73700572 |
| 13 | MP0005451_abnormal_body_composition | 2.73590187 |
| 14 | MP0002796_impaired_skin_barrier | 2.68587126 |
| 15 | MP0004381_abnormal_hair_follicle | 2.67367291 |
| 16 | MP0004215_abnormal_myocardial_fiber | 2.59902242 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.58700093 |
| 18 | MP0000383_abnormal_hair_follicle | 2.54670361 |
| 19 | MP0010678_abnormal_skin_adnexa | 2.45373943 |
| 20 | MP0001542_abnormal_bone_strength | 2.38974661 |
| 21 | MP0000647_abnormal_sebaceous_gland | 2.37952933 |
| 22 | MP0000372_irregular_coat_pigmentation | 2.37185687 |
| 23 | MP0001661_extended_life_span | 2.25567086 |
| 24 | MP0005620_abnormal_muscle_contractility | 2.24827380 |
| 25 | MP0002106_abnormal_muscle_physiology | 2.12003513 |
| 26 | MP0002295_abnormal_pulmonary_circulatio | 2.08353890 |
| 27 | MP0003690_abnormal_glial_cell | 2.08214939 |
| 28 | MP0002638_abnormal_pupillary_reflex | 2.02770646 |
| 29 | MP0008775_abnormal_heart_ventricle | 1.99477045 |
| 30 | MP0002332_abnormal_exercise_endurance | 1.97247410 |
| 31 | MP0008789_abnormal_olfactory_epithelium | 1.97233174 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.95915696 |
| 33 | MP0001346_abnormal_lacrimal_gland | 1.95232211 |
| 34 | MP0003718_maternal_effect | 1.91142107 |
| 35 | MP0002972_abnormal_cardiac_muscle | 1.89669009 |
| 36 | MP0005369_muscle_phenotype | 1.88773240 |
| 37 | MP0004272_abnormal_basement_membrane | 1.83633547 |
| 38 | MP0004484_altered_response_of | 1.83604058 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.83449479 |
| 40 | MP0002102_abnormal_ear_morphology | 1.80963497 |
| 41 | MP0006276_abnormal_autonomic_nervous | 1.77890190 |
| 42 | MP0004130_abnormal_muscle_cell | 1.72843754 |
| 43 | MP0001905_abnormal_dopamine_level | 1.70082687 |
| 44 | MP0004742_abnormal_vestibular_system | 1.64474802 |
| 45 | MP0003195_calcinosis | 1.64440570 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.63487092 |
| 47 | MP0004147_increased_porphyrin_level | 1.63018406 |
| 48 | MP0005670_abnormal_white_adipose | 1.61770851 |
| 49 | MP0000762_abnormal_tongue_morphology | 1.61143389 |
| 50 | MP0004087_abnormal_muscle_fiber | 1.60815830 |
| 51 | MP0009840_abnormal_foam_cell | 1.60709989 |
| 52 | MP0001485_abnormal_pinna_reflex | 1.59096816 |
| 53 | MP0000462_abnormal_digestive_system | 1.57020886 |
| 54 | MP0003941_abnormal_skin_development | 1.55988383 |
| 55 | MP0004885_abnormal_endolymph | 1.55311339 |
| 56 | MP0005503_abnormal_tendon_morphology | 1.54017735 |
| 57 | MP0000613_abnormal_salivary_gland | 1.51350054 |
| 58 | MP0006292_abnormal_olfactory_placode | 1.50636165 |
| 59 | MP0005310_abnormal_salivary_gland | 1.47839944 |
| 60 | MP0002098_abnormal_vibrissa_morphology | 1.46933625 |
| 61 | MP0001529_abnormal_vocalization | 1.40915299 |
| 62 | MP0004043_abnormal_pH_regulation | 1.40411791 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 1.40258185 |
| 64 | MP0002269_muscular_atrophy | 1.39450015 |
| 65 | MP0002163_abnormal_gland_morphology | 1.35911433 |
| 66 | MP0003137_abnormal_impulse_conducting | 1.35189050 |
| 67 | MP0003724_increased_susceptibility_to | 1.34736941 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 1.32624831 |
| 69 | MP0001958_emphysema | 1.32619707 |
| 70 | MP0006072_abnormal_retinal_apoptosis | 1.32607263 |
| 71 | MP0003634_abnormal_glial_cell | 1.31719309 |
| 72 | MP0002108_abnormal_muscle_morphology | 1.31574580 |
| 73 | MP0001544_abnormal_cardiovascular_syste | 1.31416403 |
| 74 | MP0005385_cardiovascular_system_phenoty | 1.31416403 |
| 75 | MP0003186_abnormal_redox_activity | 1.31079688 |
| 76 | MP0002060_abnormal_skin_morphology | 1.30759742 |
| 77 | MP0000759_abnormal_skeletal_muscle | 1.28556772 |
| 78 | MP0006082_CNS_inflammation | 1.28496568 |
| 79 | MP0005501_abnormal_skin_physiology | 1.28179724 |
| 80 | MP0003878_abnormal_ear_physiology | 1.26889468 |
| 81 | MP0005377_hearing/vestibular/ear_phenot | 1.26889468 |
| 82 | MP0003011_delayed_dark_adaptation | 1.26018187 |
| 83 | MP0005408_hypopigmentation | 1.25781553 |
| 84 | MP0002009_preneoplasia | 1.25674071 |
| 85 | MP0003329_amyloid_beta_deposits | 1.25077976 |
| 86 | MP0005266_abnormal_metabolism | 1.20888925 |
| 87 | MP0004085_abnormal_heartbeat | 1.19841804 |
| 88 | MP0004036_abnormal_muscle_relaxation | 1.18355802 |
| 89 | MP0001727_abnormal_embryo_implantation | 1.18158216 |
| 90 | MP0008877_abnormal_DNA_methylation | 1.17450130 |
| 91 | MP0001851_eye_inflammation | 1.16481903 |
| 92 | MP0008872_abnormal_physiological_respon | 1.14584410 |
| 93 | MP0002127_abnormal_cardiovascular_syste | 1.13653654 |
| 94 | MP0009780_abnormal_chondrocyte_physiolo | 1.13240631 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 1.12886305 |
| 96 | MP0004142_abnormal_muscle_tone | 1.10159852 |
| 97 | MP0002282_abnormal_trachea_morphology | 1.09946515 |
| 98 | MP0001216_abnormal_epidermal_layer | 1.09331825 |
| 99 | MP0004134_abnormal_chest_morphology | 1.08984748 |
| 100 | MP0002277_abnormal_respiratory_mucosa | 1.08287903 |
| 101 | MP0002133_abnormal_respiratory_system | 1.07742358 |
| 102 | MP0005388_respiratory_system_phenotype | 1.07742358 |
| 103 | MP0002132_abnormal_respiratory_system | 1.06848631 |
| 104 | MP0001984_abnormal_olfaction | 1.05602186 |
| 105 | MP0005508_abnormal_skeleton_morphology | 1.04934535 |
| 106 | MP0002876_abnormal_thyroid_physiology | 1.04130986 |
| 107 | MP0010771_integument_phenotype | 1.02974127 |
| 108 | MP0000377_abnormal_hair_follicle | 1.02734959 |
| 109 | MP0005645_abnormal_hypothalamus_physiol | 1.00629118 |
| 110 | MP0003787_abnormal_imprinting | 1.00014357 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.99418035 |
| 112 | MP0002736_abnormal_nociception_after | 0.99071662 |
| 113 | MP0005409_darkened_coat_color | 0.97120222 |
| 114 | MP0002090_abnormal_vision | 0.95591612 |
| 115 | MP0002751_abnormal_autonomic_nervous | 0.95538277 |
| 116 | MP0002234_abnormal_pharynx_morphology | 0.95278107 |
| 117 | MP0004133_heterotaxia | 0.95225417 |
| 118 | MP0005253_abnormal_eye_physiology | 0.94677329 |
| 119 | MP0002148_abnormal_hypersensitivity_rea | 0.94444351 |
| 120 | MP0000579_abnormal_nail_morphology | 0.94046108 |
| 121 | MP0000427_abnormal_hair_cycle | 0.93515855 |
| 122 | MP0005084_abnormal_gallbladder_morpholo | 0.93069013 |
| 123 | MP0005394_taste/olfaction_phenotype | 0.91733452 |
| 124 | MP0005499_abnormal_olfactory_system | 0.91733452 |
| 125 | MP0001243_abnormal_dermal_layer | 0.91223527 |
| 126 | MP0000747_muscle_weakness | 0.90726167 |
| 127 | MP0009250_abnormal_appendicular_skeleto | 0.89520864 |
| 128 | MP0005410_abnormal_fertilization | 0.89119891 |
| 129 | MP0000465_gastrointestinal_hemorrhage | 0.89086939 |
| 130 | MP0003315_abnormal_perineum_morphology | 0.88251664 |
| 131 | MP0005395_other_phenotype | 0.87750692 |
| 132 | MP0003632_abnormal_nervous_system | 0.85782979 |
| 133 | MP0005379_endocrine/exocrine_gland_phen | 0.85628205 |
| 134 | MP0000516_abnormal_urinary_system | 0.84019513 |
| 135 | MP0005367_renal/urinary_system_phenotyp | 0.84019513 |
| 136 | MP0001177_atelectasis | 0.83369717 |
| 137 | MP0003880_abnormal_central_pattern | 0.83141732 |
| 138 | MP0002160_abnormal_reproductive_system | 0.82753995 |
| 139 | MP0001756_abnormal_urination | 0.82436625 |
| 140 | MP0003938_abnormal_ear_development | 0.82287149 |
| 141 | MP0000049_abnormal_middle_ear | 0.81128214 |
| 142 | MP0005623_abnormal_meninges_morphology | 0.78753636 |
| 143 | MP0001968_abnormal_touch/_nociception | 0.78094412 |
| 144 | MP0002229_neurodegeneration | 0.75494729 |
| 145 | MP0004084_abnormal_cardiac_muscle | 0.75339918 |
| 146 | MP0009379_abnormal_foot_pigmentation | 0.75164611 |
| 147 | MP0000681_abnormal_thyroid_gland | 0.74946879 |
| 148 | MP0003828_pulmonary_edema | 0.74816098 |
| 149 | MP0003638_abnormal_response/metabolism_ | 0.73470125 |
| 150 | MP0004233_abnormal_muscle_weight | 0.73297159 |
| 151 | MP0004510_myositis | 0.72068353 |
| 152 | MP0000467_abnormal_esophagus_morphology | 0.71012966 |
| 153 | MP0003806_abnormal_nucleotide_metabolis | 0.69014787 |
| 154 | MP0000013_abnormal_adipose_tissue | 0.68829082 |
| 155 | MP0000631_abnormal_neuroendocrine_gland | 0.68534239 |
| 156 | MP0010386_abnormal_urinary_bladder | 0.67268042 |
| 157 | MP0005083_abnormal_biliary_tract | 0.67085140 |
| 158 | MP0006035_abnormal_mitochondrial_morpho | 0.65974917 |
| 159 | MP0005330_cardiomyopathy | 0.65967251 |
| 160 | MP0005167_abnormal_blood-brain_barrier | 0.65778725 |
| 161 | MP0000750_abnormal_muscle_regeneration | 0.65065331 |
| 162 | MP0002938_white_spotting | 0.62930663 |
| 163 | MP0001440_abnormal_grooming_behavior | 0.62682660 |
| 164 | MP0010030_abnormal_orbit_morphology | 0.61539853 |
| 165 | MP0006138_congestive_heart_failure | 0.61391011 |
| 166 | MP0002254_reproductive_system_inflammat | 0.60610759 |
| 167 | MP0001963_abnormal_hearing_physiology | 0.60417426 |
| 168 | MP0000230_abnormal_systemic_arterial | 0.60307937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 6.28691357 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 6.22809154 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.02106436 |
| 4 | Parakeratosis (HP:0001036) | 5.85823182 |
| 5 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.39836176 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 4.75841295 |
| 7 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.68979825 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 4.67141935 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.36672621 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 4.20194308 |
| 11 | Cerebral hypomyelination (HP:0006808) | 4.02494455 |
| 12 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.57216146 |
| 13 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.57216146 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 3.53616334 |
| 15 | Exercise-induced myalgia (HP:0003738) | 3.50543797 |
| 16 | Abnormality of glycolysis (HP:0004366) | 3.44562672 |
| 17 | Increased serum pyruvate (HP:0003542) | 3.44562672 |
| 18 | Distal arthrogryposis (HP:0005684) | 3.23633369 |
| 19 | Rimmed vacuoles (HP:0003805) | 3.20518570 |
| 20 | True hermaphroditism (HP:0010459) | 3.16122175 |
| 21 | Pancreatic cysts (HP:0001737) | 3.09646286 |
| 22 | Myoglobinuria (HP:0002913) | 3.07839374 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 3.06018363 |
| 24 | Abnormality of the umbilical cord (HP:0010881) | 3.05394056 |
| 25 | Acute necrotizing encephalopathy (HP:0006965) | 3.04627513 |
| 26 | Neurofibrillary tangles (HP:0002185) | 3.03860200 |
| 27 | Prolonged neonatal jaundice (HP:0006579) | 2.99281265 |
| 28 | Pancreatic fibrosis (HP:0100732) | 2.98161437 |
| 29 | Sensory axonal neuropathy (HP:0003390) | 2.94606623 |
| 30 | EMG: myopathic abnormalities (HP:0003458) | 2.91535921 |
| 31 | Bundle branch block (HP:0011710) | 2.82290433 |
| 32 | Renal Fanconi syndrome (HP:0001994) | 2.81259231 |
| 33 | Hepatosplenomegaly (HP:0001433) | 2.75946242 |
| 34 | Spastic paraparesis (HP:0002313) | 2.75161081 |
| 35 | Mitochondrial inheritance (HP:0001427) | 2.65412133 |
| 36 | Muscle fiber splitting (HP:0003555) | 2.64493728 |
| 37 | Patchy hypopigmentation of hair (HP:0011365) | 2.64418765 |
| 38 | Increased hepatocellular lipid droplets (HP:0006565) | 2.64068494 |
| 39 | Neck muscle weakness (HP:0000467) | 2.62777406 |
| 40 | Absent phalangeal crease (HP:0006109) | 2.62117778 |
| 41 | Premature rupture of membranes (HP:0001788) | 2.59824198 |
| 42 | Sudden death (HP:0001699) | 2.59476291 |
| 43 | Abnormality of midbrain morphology (HP:0002418) | 2.59056154 |
| 44 | Molar tooth sign on MRI (HP:0002419) | 2.59056154 |
| 45 | Rhabdomyolysis (HP:0003201) | 2.57958975 |
| 46 | Stenosis of the external auditory canal (HP:0000402) | 2.56607094 |
| 47 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.53856274 |
| 48 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.53101636 |
| 49 | Single umbilical artery (HP:0001195) | 2.53101636 |
| 50 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.53101636 |
| 51 | Adrenal hypoplasia (HP:0000835) | 2.51942015 |
| 52 | Congenital malformation of the right heart (HP:0011723) | 2.51795021 |
| 53 | Double outlet right ventricle (HP:0001719) | 2.51795021 |
| 54 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.50861419 |
| 55 | Leukodystrophy (HP:0002415) | 2.48152904 |
| 56 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.47586071 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 2.47047046 |
| 58 | Hepatic necrosis (HP:0002605) | 2.43891612 |
| 59 | Hepatocellular necrosis (HP:0001404) | 2.43196786 |
| 60 | 3-Methylglutaconic aciduria (HP:0003535) | 2.42895952 |
| 61 | Nephronophthisis (HP:0000090) | 2.41923805 |
| 62 | Lipid accumulation in hepatocytes (HP:0006561) | 2.41447659 |
| 63 | CNS hypomyelination (HP:0003429) | 2.39129073 |
| 64 | White forelock (HP:0002211) | 2.37778810 |
| 65 | Peripheral hypomyelination (HP:0007182) | 2.36606556 |
| 66 | Oligomenorrhea (HP:0000876) | 2.34668718 |
| 67 | Abnormality of placental membranes (HP:0011409) | 2.33631254 |
| 68 | Amniotic constriction ring (HP:0009775) | 2.33631254 |
| 69 | Progressive macrocephaly (HP:0004481) | 2.32248374 |
| 70 | Exercise intolerance (HP:0003546) | 2.31763055 |
| 71 | Ileus (HP:0002595) | 2.29104970 |
| 72 | Erythroderma (HP:0001019) | 2.29041063 |
| 73 | Conical tooth (HP:0000698) | 2.29028644 |
| 74 | Acute encephalopathy (HP:0006846) | 2.28863064 |
| 75 | Abnormal finger flexion creases (HP:0006143) | 2.25268084 |
| 76 | Myotonia (HP:0002486) | 2.24378766 |
| 77 | Abnormality of the renal cortex (HP:0011035) | 2.23924430 |
| 78 | Vacuolated lymphocytes (HP:0001922) | 2.22665390 |
| 79 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.22628671 |
| 80 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.22460264 |
| 81 | Abnormality of alanine metabolism (HP:0010916) | 2.22460264 |
| 82 | Hyperalaninemia (HP:0003348) | 2.22460264 |
| 83 | Cerebral edema (HP:0002181) | 2.22229286 |
| 84 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.20548854 |
| 85 | Osteolytic defects of the hand bones (HP:0009699) | 2.20548854 |
| 86 | Myopathic facies (HP:0002058) | 2.20337792 |
| 87 | Abnormality of macrophages (HP:0004311) | 2.18823536 |
| 88 | Renal cortical cysts (HP:0000803) | 2.17849683 |
| 89 | Areflexia of lower limbs (HP:0002522) | 2.15962935 |
| 90 | Cerebral hemorrhage (HP:0001342) | 2.15922898 |
| 91 | Ulnar deviation of the wrist (HP:0003049) | 2.15566337 |
| 92 | Split foot (HP:0001839) | 2.14525365 |
| 93 | Type II lissencephaly (HP:0007260) | 2.13588694 |
| 94 | Aplasia of the musculature (HP:0100854) | 2.12014937 |
| 95 | Abnormal hemoglobin (HP:0011902) | 2.11442663 |
| 96 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.11370034 |
| 97 | Left ventricular hypertrophy (HP:0001712) | 2.09587285 |
| 98 | Abnormality of the renal medulla (HP:0100957) | 2.08843022 |
| 99 | Congenital, generalized hypertrichosis (HP:0004540) | 2.08452979 |
| 100 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.08216591 |
| 101 | Hypoplastic pelvis (HP:0008839) | 2.08168471 |
| 102 | Lactic acidosis (HP:0003128) | 2.06410410 |
| 103 | Increased intramyocellular lipid droplets (HP:0012240) | 2.05849412 |
| 104 | Abnormality of the corticospinal tract (HP:0002492) | 2.05348043 |
| 105 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.04981842 |
| 106 | Hypoplasia of the fovea (HP:0007750) | 2.04981842 |
| 107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03441094 |
| 108 | Optic disc pallor (HP:0000543) | 2.02292003 |
| 109 | Cupped ear (HP:0000378) | 2.02270601 |
| 110 | Congenital stationary night blindness (HP:0007642) | 2.02205281 |
| 111 | Abnormality of secondary sexual hair (HP:0009888) | 2.01733931 |
| 112 | Abnormality of the axillary hair (HP:0100134) | 2.01733931 |
| 113 | Breast hypoplasia (HP:0003187) | 2.01569337 |
| 114 | Retinal dysplasia (HP:0007973) | 2.00358669 |
| 115 | Methylmalonic acidemia (HP:0002912) | 1.99735405 |
| 116 | Pendular nystagmus (HP:0012043) | 1.99637567 |
| 117 | Ventricular tachycardia (HP:0004756) | 1.99588910 |
| 118 | Increased CSF lactate (HP:0002490) | 1.99334402 |
| 119 | Onion bulb formation (HP:0003383) | 1.96634042 |
| 120 | Postnatal microcephaly (HP:0005484) | 1.96472418 |
| 121 | Abnormality of renal resorption (HP:0011038) | 1.95894141 |
| 122 | Type 2 muscle fiber atrophy (HP:0003554) | 1.95341815 |
| 123 | Palpitations (HP:0001962) | 1.94751737 |
| 124 | Hypoplasia of the uterus (HP:0000013) | 1.94277357 |
| 125 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.94011831 |
| 126 | Dilated cardiomyopathy (HP:0001644) | 1.92462745 |
| 127 | Furrowed tongue (HP:0000221) | 1.92079995 |
| 128 | Increased muscle lipid content (HP:0009058) | 1.91658332 |
| 129 | Respiratory failure (HP:0002878) | 1.91444156 |
| 130 | Gait imbalance (HP:0002141) | 1.91433956 |
| 131 | Syncope (HP:0001279) | 1.91411180 |
| 132 | Stridor (HP:0010307) | 1.89931518 |
| 133 | Distal lower limb muscle weakness (HP:0009053) | 1.89855302 |
| 134 | Premature skin wrinkling (HP:0100678) | 1.89425957 |
| 135 | Hypokalemic alkalosis (HP:0001949) | 1.89072763 |
| 136 | Absent hand (HP:0004050) | 1.88900507 |
| 137 | Abnormality of the neuromuscular junction (HP:0003398) | 1.88855507 |
| 138 | Fatigable weakness (HP:0003473) | 1.88855507 |
| 139 | Lipoatrophy (HP:0100578) | 1.88848049 |
| 140 | Frequent falls (HP:0002359) | 1.88716797 |
| 141 | EMG: neuropathic changes (HP:0003445) | 1.87863905 |
| 142 | Morphological abnormality of the inner ear (HP:0011390) | 1.86785031 |
| 143 | Abolished electroretinogram (ERG) (HP:0000550) | 1.86660816 |
| 144 | Keratoconus (HP:0000563) | 1.86554480 |
| 145 | Increased corneal curvature (HP:0100692) | 1.86554480 |
| 146 | Nephrogenic diabetes insipidus (HP:0009806) | 1.86099622 |
| 147 | Congenital primary aphakia (HP:0007707) | 1.86013403 |
| 148 | Thick nail (HP:0001805) | 1.84101090 |
| 149 | Methylmalonic aciduria (HP:0012120) | 1.83950057 |
| 150 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83018205 |
| 151 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83018205 |
| 152 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83018205 |
| 153 | Round ear (HP:0100830) | 1.82800573 |
| 154 | Decreased central vision (HP:0007663) | 1.82783437 |
| 155 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.81837510 |
| 156 | Increased serum lactate (HP:0002151) | 1.81778722 |
| 157 | Delayed epiphyseal ossification (HP:0002663) | 1.81761357 |
| 158 | Anomalous pulmonary venous return (HP:0010772) | 1.80586318 |
| 159 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.80574789 |
| 160 | Autoamputation (HP:0001218) | 1.80060323 |
| 161 | Hypoplastic left heart (HP:0004383) | 1.79342574 |
| 162 | Ureteral duplication (HP:0000073) | 1.78625215 |
| 163 | Malignant hyperthermia (HP:0002047) | 1.77636352 |
| 164 | Septate vagina (HP:0001153) | 1.77614834 |
| 165 | Paraparesis (HP:0002385) | 1.76805825 |
| 166 | Sparse eyelashes (HP:0000653) | 1.76649854 |
| 167 | Rough bone trabeculation (HP:0100670) | 1.76424210 |
| 168 | Abnormal trabecular bone morphology (HP:0100671) | 1.75279322 |
| 169 | Abnormality of the pulmonary veins (HP:0011718) | 1.74623146 |
| 170 | Delayed gross motor development (HP:0002194) | 1.74414721 |
| 171 | Anencephaly (HP:0002323) | 1.74168167 |
| 172 | Multiple enchondromatosis (HP:0005701) | 1.74138756 |
| 173 | Sclerocornea (HP:0000647) | 1.73591344 |
| 174 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.73437333 |
| 175 | Increased circulating renin level (HP:0000848) | 1.73257668 |
| 176 | Glycosuria (HP:0003076) | 1.73039066 |
| 177 | Abnormality of the fovea (HP:0000493) | 1.72164980 |
| 178 | Hip contracture (HP:0003273) | 1.72156847 |
| 179 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.71906260 |
| 180 | Dicarboxylic aciduria (HP:0003215) | 1.71906260 |
| 181 | Congenital hepatic fibrosis (HP:0002612) | 1.71706467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.32913990 |
| 2 | OXSR1 | 3.56267705 |
| 3 | PHKG1 | 3.54526422 |
| 4 | PHKG2 | 3.54526422 |
| 5 | EPHB1 | 3.24057351 |
| 6 | MST4 | 3.13965653 |
| 7 | PBK | 2.88191341 |
| 8 | STK16 | 2.86105543 |
| 9 | BUB1 | 2.80779917 |
| 10 | MAP4K2 | 2.61510890 |
| 11 | VRK2 | 2.58827279 |
| 12 | FRK | 2.54790205 |
| 13 | BCR | 2.40519728 |
| 14 | MAPKAPK5 | 2.39217115 |
| 15 | EPHA2 | 2.31250206 |
| 16 | NME2 | 2.24519495 |
| 17 | MAPKAPK3 | 2.17830390 |
| 18 | MET | 2.12924265 |
| 19 | WNK4 | 1.98916452 |
| 20 | TNIK | 1.78602746 |
| 21 | MAPK13 | 1.76798010 |
| 22 | WNK3 | 1.76740985 |
| 23 | MAPK15 | 1.71821587 |
| 24 | TTN | 1.71189029 |
| 25 | AKT3 | 1.60398631 |
| 26 | ARAF | 1.59890158 |
| 27 | PKN1 | 1.54553626 |
| 28 | PIM2 | 1.52924968 |
| 29 | LIMK1 | 1.51325516 |
| 30 | ERBB3 | 1.49288581 |
| 31 | IRAK1 | 1.46331093 |
| 32 | MARK1 | 1.42015082 |
| 33 | IRAK3 | 1.41044209 |
| 34 | TRIM28 | 1.37568275 |
| 35 | MAP3K12 | 1.35638410 |
| 36 | TESK2 | 1.34361040 |
| 37 | NME1 | 1.24903993 |
| 38 | IRAK4 | 1.23286742 |
| 39 | NEK1 | 1.15436219 |
| 40 | NEK6 | 1.15270248 |
| 41 | IRAK2 | 1.14498320 |
| 42 | GRK7 | 1.13548872 |
| 43 | MYLK | 1.10408784 |
| 44 | CSNK1G1 | 1.09034573 |
| 45 | MAP2K2 | 1.07038426 |
| 46 | NUAK1 | 1.06889067 |
| 47 | CSNK1G3 | 1.05486405 |
| 48 | NLK | 1.04081079 |
| 49 | PNCK | 1.03887216 |
| 50 | CAMK2D | 1.03219717 |
| 51 | STK38L | 1.02286087 |
| 52 | EIF2AK3 | 1.02015784 |
| 53 | ROCK2 | 0.98671394 |
| 54 | TAOK3 | 0.98579934 |
| 55 | ADRBK1 | 0.97704100 |
| 56 | ZAK | 0.97626108 |
| 57 | TIE1 | 0.96237622 |
| 58 | CAMK2B | 0.96055179 |
| 59 | INSRR | 0.95299040 |
| 60 | BMPR1B | 0.94798816 |
| 61 | DYRK2 | 0.94601459 |
| 62 | MAP2K7 | 0.92426192 |
| 63 | TGFBR1 | 0.92253619 |
| 64 | MAP3K3 | 0.92076872 |
| 65 | WNK1 | 0.88409670 |
| 66 | CDK19 | 0.86860256 |
| 67 | TRPM7 | 0.85131449 |
| 68 | RPS6KA5 | 0.84567458 |
| 69 | STK24 | 0.84383493 |
| 70 | EPHA3 | 0.83561566 |
| 71 | CSNK1A1L | 0.82984547 |
| 72 | PRKCE | 0.82913925 |
| 73 | CDK3 | 0.81459864 |
| 74 | MAP3K4 | 0.79637087 |
| 75 | PTK2B | 0.79033222 |
| 76 | PIK3CA | 0.78908106 |
| 77 | BRSK2 | 0.78800000 |
| 78 | WEE1 | 0.78474327 |
| 79 | BMPR2 | 0.77094788 |
| 80 | ACVR1B | 0.75906746 |
| 81 | FGR | 0.74657622 |
| 82 | FGFR2 | 0.74304693 |
| 83 | CAMK2G | 0.72991799 |
| 84 | MST1R | 0.72244207 |
| 85 | TAF1 | 0.71493940 |
| 86 | PLK2 | 0.70379059 |
| 87 | TGFBR2 | 0.68973732 |
| 88 | PDK2 | 0.66319099 |
| 89 | PAK1 | 0.64924459 |
| 90 | PINK1 | 0.64352887 |
| 91 | TSSK6 | 0.63886948 |
| 92 | MUSK | 0.63280973 |
| 93 | DYRK3 | 0.62686552 |
| 94 | NTRK1 | 0.62625018 |
| 95 | GRK1 | 0.61107230 |
| 96 | CAMK2A | 0.61098781 |
| 97 | MKNK1 | 0.60314451 |
| 98 | IKBKB | 0.60201175 |
| 99 | STK3 | 0.59834257 |
| 100 | MAP2K6 | 0.59527491 |
| 101 | FER | 0.59329188 |
| 102 | MAP3K2 | 0.57560009 |
| 103 | OBSCN | 0.56563453 |
| 104 | ILK | 0.56380806 |
| 105 | PLK4 | 0.55503058 |
| 106 | SGK223 | 0.54063162 |
| 107 | SGK494 | 0.54063162 |
| 108 | TESK1 | 0.53582874 |
| 109 | CASK | 0.53053443 |
| 110 | CLK1 | 0.52486163 |
| 111 | LMTK2 | 0.51170198 |
| 112 | CCNB1 | 0.50412600 |
| 113 | ABL2 | 0.48232753 |
| 114 | VRK1 | 0.47574415 |
| 115 | PRKD1 | 0.47086016 |
| 116 | PRKACA | 0.46925686 |
| 117 | ADRBK2 | 0.46480850 |
| 118 | GSK3A | 0.45454600 |
| 119 | TXK | 0.45313795 |
| 120 | MAPKAPK2 | 0.44915117 |
| 121 | MAP2K1 | 0.43845009 |
| 122 | EIF2AK1 | 0.43795406 |
| 123 | ROCK1 | 0.43693837 |
| 124 | TLK1 | 0.43055953 |
| 125 | PIK3CG | 0.42240247 |
| 126 | PRKCG | 0.42148243 |
| 127 | UHMK1 | 0.40509275 |
| 128 | GRK5 | 0.40468533 |
| 129 | LRRK2 | 0.40367773 |
| 130 | DAPK2 | 0.39953145 |
| 131 | CSNK1G2 | 0.39360135 |
| 132 | CAMK1 | 0.39125518 |
| 133 | PAK3 | 0.38906144 |
| 134 | DAPK3 | 0.38343565 |
| 135 | MAP2K4 | 0.37536628 |
| 136 | MAP3K7 | 0.37476954 |
| 137 | PRKCQ | 0.36774009 |
| 138 | CSNK1A1 | 0.36235507 |
| 139 | DMPK | 0.36104333 |
| 140 | PRKG1 | 0.35809771 |
| 141 | EIF2AK2 | 0.35719575 |
| 142 | PRKAA2 | 0.35675523 |
| 143 | PRKAA1 | 0.34836122 |
| 144 | PRKCI | 0.34828646 |
| 145 | EPHB2 | 0.33204191 |
| 146 | BCKDK | 0.31487141 |
| 147 | PLK3 | 0.30901270 |
| 148 | RPS6KB2 | 0.30615381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.67132538 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.29530804 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.25085813 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.48103779 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.28275871 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.07264871 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.86503951 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.48962576 |
| 9 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.40517563 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.34025476 |
| 11 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.29621063 |
| 12 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.25310354 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.18248013 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 2.14935058 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.11156932 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.07873937 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.02287832 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.97371369 |
| 19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.76867800 |
| 20 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.73616475 |
| 21 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.68713323 |
| 22 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.67353132 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.62736365 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.61199471 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.60690190 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.57370156 |
| 27 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.57238665 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.54118665 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.52593006 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.49975661 |
| 31 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.47306443 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46825108 |
| 33 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.45174889 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42534012 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.40093782 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39956148 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.33401358 |
| 38 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.31113311 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.29757188 |
| 40 | Circadian rhythm_Homo sapiens_hsa04710 | 1.29536001 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.27791442 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09049924 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05333063 |
| 44 | RNA degradation_Homo sapiens_hsa03018 | 1.03873164 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00063578 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.98358379 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95205688 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94262899 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93995030 |
| 50 | Homologous recombination_Homo sapiens_hsa03440 | 0.93018711 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91410358 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.90518565 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90297081 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.90073331 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89837783 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88541755 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.88331380 |
| 58 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87187949 |
| 59 | Mineral absorption_Homo sapiens_hsa04978 | 0.86421397 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.85724088 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85717443 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83385665 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.83224428 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82811110 |
| 65 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82543631 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.81962453 |
| 67 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81218001 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80284096 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78435516 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77605600 |
| 71 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77017747 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71311532 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69856029 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69525754 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67504571 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67336518 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67308506 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.63415858 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62733511 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62450769 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60525630 |
| 82 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58373199 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56842164 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56328710 |
| 85 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.54570526 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.53220703 |
| 87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52161197 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51914176 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.51795755 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51353357 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50280131 |
| 92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49733103 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47583304 |
| 94 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.47527003 |
| 95 | Taste transduction_Homo sapiens_hsa04742 | 0.45634372 |
| 96 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.45431526 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45239232 |
| 98 | Axon guidance_Homo sapiens_hsa04360 | 0.44664910 |
| 99 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.44052775 |
| 100 | Mismatch repair_Homo sapiens_hsa03430 | 0.42075699 |
| 101 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41411313 |
| 102 | Salivary secretion_Homo sapiens_hsa04970 | 0.41363688 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38157866 |
| 104 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37347685 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37202668 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36110626 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.35719701 |
| 108 | Nicotine addiction_Homo sapiens_hsa05033 | 0.35443566 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.35160115 |
| 110 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.34276560 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33643715 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32303595 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32041062 |
| 114 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.31859786 |
| 115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31562160 |
| 116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.31217715 |
| 117 | GABAergic synapse_Homo sapiens_hsa04727 | 0.30163005 |
| 118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.28167712 |
| 119 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27386644 |
| 120 | Insulin secretion_Homo sapiens_hsa04911 | 0.27191580 |
| 121 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25751275 |
| 122 | Allograft rejection_Homo sapiens_hsa05330 | 0.25304510 |
| 123 | Asthma_Homo sapiens_hsa05310 | 0.23245593 |
| 124 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.20207783 |
| 125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19753078 |
| 126 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.19688125 |
| 127 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.19386900 |
| 128 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.17912471 |
| 129 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.17226425 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.15334363 |
| 131 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.14346234 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.13381722 |
| 133 | Hepatitis C_Homo sapiens_hsa05160 | 0.13104707 |
| 134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.11793692 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.11746202 |
| 136 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11654723 |
| 137 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.10782231 |
| 138 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.10168340 |
| 139 | Prostate cancer_Homo sapiens_hsa05215 | 0.09682302 |
| 140 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.09326936 |
| 141 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.08465794 |
| 142 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.07109541 |

